CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.000
+0.080 (4.17%)
Nov 14, 2025, 4:00 PM EST - Market closed

CytoMed Therapeutics Revenue

CytoMed Therapeutics had revenue of 450.69K SGD in the half year ending June 30, 2025, with 58.57% growth. This brings the company's revenue in the last twelve months to 729.88K, up 63.03% year-over-year. In the year 2024, CytoMed Therapeutics had annual revenue of 503.37K, down -0.86%.

Revenue (ttm)
729.88K SGD
Revenue Growth
+63.03%
P/S Ratio
39.46
Revenue / Employee
16,974 SGD
Employees
43
Market Cap
23.08M USD

Revenue Chart

* This company reports financials in SGD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024503.37K-4.36K-0.86%
Dec 31, 2023507.74K143.82K39.52%
Dec 31, 2022363.91K250.07K219.67%
Dec 31, 2021113.84K54.37K91.43%
Dec 31, 202059.47K--
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings